Saudi Chemical gets SFDA approval on pharma product

09/02/2025 Argaam
Logo of Saudi Chemical Co. Holding

Logo of Saudi Chemical Co. Holding

Saudi Chemical Co. Holding obtained the Saudi Food and Drug Authority’s (SFDA) approval to register Ticagrelor as a fully locally manufactured product at the AJA Pharmaceutical Industries Ltd. (AJA Pharma) factory.

 

In a statement to Tadawul today, Feb. 9, the Saudi-listed company expected the move to fuel a more than SAR 35 million revenue increase over a five-year period after marketing.

 

For more news on listed companies

 

According to data compiled by Argaam, Saudi Chemical, represented by AJA Pharma, signed in January 2024 a contract with the Local Content and Government Procurement Authority (LCGPA) for the localization and technology transfer of the pharmaceutical product, Ticagrelor, for its inclusion on the mandatory list.

 

Ticagrelor is the first drug to be entirely manufactured locally. It is critical for the prevention of strokes and heart attacks.

Comments {{getCommentCount()}}

Be the first to comment

{{comment.FollowersCount}}
{{comment.CommenterComments}}

رد{{comment.DisplayName}} على {{getCommenterName(comment.ParentThreadID)}}

{{comment.DisplayName}} حساب موثّق

{{comment.ElapsedTime}}
{{comment.Replies.length}}
تعديل
loader Train
Report
loader Train
Sorry: the validity period has ended to comment on this news
Opinions expressed in the comments section do not reflect the views of Argaam. Abusive comments of any kind will be removed. Political or religious commentary will not be tolerated.